Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: Pharma
AstraZeneca’s first foray into the PD-L1 inhibitor Imfinzi to treat bladder cancer was a huge…
Biopharmaceutical leaders are rallying behind Pazdur in his bid to become FDA commissioner. But does he want the role?
By healthadmin
With the FDA now rudderless with the announcement that Commissioner Marty McCully, M.D., is resigning,…
The FDA aims to save money on approved drugs. Through the newly proposed reuse initiative,…
Generic drug giant Sun Pharma is recalling one lot of its chemotherapy drug in the…
BeOne’s Venclexta Challenger Beqalzi Wins FDA Approval as First BCL-2 for Mantle Cell Lymphoma
By healthadmin
BeOne Medicines has entered the BCL-2 space, securing FDA green light for Beqalzi, carving out…
CEOs of major pharmaceutical companies were conspicuously absent during President Trump’s arrival in China
By healthadmin
As President Donald Trump arrives in Beijing, one key industry is missing from his business…
In April 2025, Merck KGaA acquired SpringWorks Therapeutics, a Connecticut-based company specializing in rare diseases,…
Takeda Pharmaceutical plans to cut 4,500 jobs in the latest restructuring drive as it slims down for a “new era”
By healthadmin
With a new CEO set to take over next month and three major launches planned…
As GLP-1 competition intensifies, Novo and Lilly tout their respective early response and weight loss maintenance data
By healthadmin
Eli Lilly and Novo Nordisk are building a case for both old and new incretin…
BioMarin consolidates staff at Amicus headquarters after closing $4.8 billion deal with rare disease peer
By healthadmin
BioMarin Pharmaceuticals is consolidating employees tied to the acquired company’s headquarters in Princeton, New Jersey,…